OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

KYOWA KIRIN CO. LTD./  JP3256000005  /

Berlin
2024-09-17  9:05:05 PM Chg. +0.200 Volume Bid2024-09-17 Ask2024-09-17 Market Capitalization Dividend Y. P/E Ratio
20.800EUR +0.97% 0
Turnover: 0.000		 -Bid Size: - -Ask Size: - 11.24 bill.EUR - -
GlobeNewswire 08-28 Orchard Therapeutics Announces Multiple Presentations from across its Late-stage Neurometabolic Port...
GlobeNewswire 08-08 Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire 08-01 Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 08-01 Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08-01 BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
GlobeNewswire 08-01 Pharming Group reports second quarter and first half 2024 financial results and provides business up...
GlobeNewswire 07-31 Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Tri...
GlobeNewswire 07-18 Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024
GlobeNewswire 07-17 Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinical...
GlobeNewswire 07-02 To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA
GlobeNewswire 06-28 Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Heal...
GlobeNewswire 06-28 Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on Intern...
GlobeNewswire 06-13 Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
GlobeNewswire 05-30 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 05-23 Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first pote...
GlobeNewswire 05-22 Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
GlobeNewswire 05-21 Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapano...
GlobeNewswire 05-16 Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GlobeNewswire 05-15 Lantheus Announces Executive Appointments to Accelerate Innovation
GlobeNewswire 05-14 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 05-08 Pharming Group reports first quarter 2024 financial results and provides business update
GlobeNewswire 05-07 Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Ir...
GlobeNewswire 05-07 Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
GlobeNewswire 05-03 Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024...
GlobeNewswire 05-02 Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update